Company / CapEx per Share
Niagen Bioscience, Inc. CapEx per Share History
FY2016-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$13.49
FY2019
5-year range
-
FY2016-FY2019
Trend
+63114.5%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
CapEx per Share changed +63114% YoY in FY2019, a notable deviation from the 3-year average annual change of +21019%.
Based on SEC 10-K filings.
13.49 in FY2019 with a 3-year CAGR of +585.9%.
Improved from $0.03 to $13.49 over the past 2 years.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +585.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, capex per share increased 63114.5% year-over-year.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | $13.49 | +63114.5% |
| FY2018 | $0.02 | -31.4% |
| FY2017 | $0.03 | -25.6% |
| FY2016 | $0.04 | +737.8% |
As of FY2019 · SEC 10-K · Updated Jun 28, 2026